Table. Patient Characteristics.
| Characteristic | Total cohort (n = 70) | 2019 Cohort (n = 35) | 2020 Cohort (n = 35) |
|---|---|---|---|
| Sex, No. | |||
| Female | 34 | 16 | 18 |
| Male | 36 | 19 | 17 |
| Age, mean (SD), y | 67 (12) | 68 (10) | 65 (14) |
| Cancer stage, No. (%) | |||
| I | 12 (17.1) | 6 (17.1) | 6 (17.1) |
| II | 14 (20) | 7 (20) | 7 (20) |
| III | 11 (15.7) | 6 (17.1) | 5 (14.3) |
| IVA | 16 (22.9) | 12 (34.3) | 5 (14.3) |
| IVB | 16 (22.9) | 4 (11.4) | 12 (34.3) |
| Therapy, No. (%) | |||
| Surgery | 41 (58.6) | 25 (71.4) | 16 (45.7) |
| Radiotherapy | 6 (8.6) | 1 (2.9) | 5 (14.3) |
| Chemotherapy | 1 (1.4) | 0 | 1 (2.9) |
| Radio/chemotherapy | 12 (17.1) | 7 (20) | 5 (14.3) |
| Refused/lost at follow-up | (14.3) | 2 (5.7) | 8 (22.9) |
| Delay, mean (SD), d | |||
| D1 | 100.56 (64.89) | 82.77 (46.94) | 118.34 (75.44) |
| D2 | 35.91 (36.98) | 25.20 (22) | 46.63 (45.34) |
| D3 | 23.75 (25.52) | 26.82 (31.76) | 20.00 (14.50) |
| DD | 136.47 (71.34) | 107.97 (53.14) | 164.97 (76.36) |
Abbreviations: D1, patient delay; D2, professional delay; D3, treatment delay; DD, total diagnostic delay.